Abstract
Patency evaluation of the self-expandable Pulsar-18 nitinol stent in patients for the treatment of femoro-popliteal occlusive disease in a national multicenter prospective all comers registry with a follow up period of 12 months. Between 01/2012 and 08/2012 this all comers multicenter prospective
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
